LifeTM: Bioethics, Biopolitics, Bioeconomics: Difference between revisions
| Line 6: | Line 6: | ||
Something by Carl Eliott | Something by Carl Eliott | ||
Jocelyn E Mackie, Andrew D Taylor, David L Finegold, Abdallah S Daar, Peter A Singer | Jocelyn E Mackie, Andrew D Taylor, David L Finegold, Abdallah S Daar, Peter A Singer<br> | ||
[http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.0030129 Lessons on Ethical Decision Making from the Bioscience Industry] | |||
Carlos Novas<br> | |||
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.0030142 | [http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.0030142 What Is the Bioscience Industry Doing to Address the Ethical Issues It Faces?] | ||
Ezekiel J Emanuel, Trudo Lemmens, Carl Elliot<br> | |||
[http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.0030309 Should Society Allow Research Ethics Boards to Be Run As For-Profit Enterprises?] | |||
Revision as of 13:53, 19 June 2011
LifeTM: Bioethics, Biopolitics, Bioeconomics
Bioindustry
Something by Carl Eliott
Jocelyn E Mackie, Andrew D Taylor, David L Finegold, Abdallah S Daar, Peter A Singer
Lessons on Ethical Decision Making from the Bioscience Industry
Carlos Novas
What Is the Bioscience Industry Doing to Address the Ethical Issues It Faces?
Ezekiel J Emanuel, Trudo Lemmens, Carl Elliot
Should Society Allow Research Ethics Boards to Be Run As For-Profit Enterprises?
VV The Haunting of Medical Journals: How Ghostwriting Sold “HRT” Adriane J. Fugh-Berman /Bioethics Non-Clinical Medicine/Communication in Health PLoS Medicine: Policy Forum, published 07 Sep 2010 [yes]
VV Regulating the Market in Human Research Participants [2006, yes - economics]
VV Strategies and Practices in Off-Label Marketing of Pharmaceuticals: A Retrospective Analysis of Whistleblower Complaints Aaron S. Kesselheim, Michelle M. Mello, David M. Studdert Faculty Scholars Program in Bioethics. DMS is supported PLoS Medicine: Research Article, published 05 Apr 2011 [yes]
VV Doctors and Drug Companies: Still Cozy after All These Years David Henry in Medical Practice Non-Clinical Medicine/Bioethics Non PLoS Medicine: Perspective, published 02 Nov 2010 [yes, short]
Biovalue
V Should Informed Consent for Cancer Treatment Include a Discussion about Hospital Outcome Disparities? Nadine Housri, Robert J Weil, David I Shalowitz, Leonidas G Koniaris [possible, 2008, socio-cultural, economic - interesting issue raised - q of individual consent is not just individual but also political and economic]
V Synthetic Biology: Caught between Property Rights, the Public Domain, and the Commons Arti Rai, James Boyle raised issues ranging from bioethical and environmental PLoS Biology: Essay, published 13 Mar 2007 [more because it’s interesting - not sure about direct relevance?]
VV Synthetic biology and the ethics of knowledge Thomas Douglas and Julian Savulescu J Med Ethics. Author manuscript; available in PMC 2011 May 1. PMCID: PMC3045879
VV The International Patent System and Biomedical Research: Reconciling Aspiration, Policy and Practice Antony Taubman, 2008
VV “Anything you can do, I can do bigger?”: the ethics and equity of growth hormone for small normal children D G Gill, 2006
VV Is It Ethical for Patients with Renal Disease to Purchase Kidneys from the World's Poor? Tarif Bakdash, Nancy Scheper-Hughes The PLoS Medicine Debate Non-Clinical Medicine/Bioethics ... neurologist and Assistant Professor in Bioethics at Damascus ... the Master of Health Science in Bioethics at The Joint [yes, 2004]
VV The "spare parts person"? Conceptions of the human body and their implications for public attitudes towards organ donation and organ sale Mark Schweda* and Silke Schicktanz [2009; organs - yes] http://www.peh-med.com/content/4/1/4
V Directed organ donation: is the donor the owner? Antonia J Cronin and David Price Clin Ethics. Author manuscript; available in PMC 2010 October 1/2008.
V Thinking About the Human Neuron Mouse Henry T. Greely, Mildred K. Cho, Linda F. Hogle, and Debra M. Satz Am J Bioeth. Author manuscript; available in PMC 2008 January 30.
VV The thousand-dollar genome. Genetic brinkmanship or personalized medicine? Howard Wolinsky EMBO Rep. 2007 October; 8(10): 900–903. doi: 10.1038/sj.embor.7401070. PMCID: PMC2002559 | Full Text | PDF–272K |
VV National Biobanks: Clinical Labor, Risk Production, and the Creation of Biovalue Robert Mitchell Sci Technol Human Values. Author manuscript; available in PMC 2011 May 1.
Biopolitics
V The end of the era of generosity? Global health amid economic crisis Kammerle Schneider* and Laurie Garrett , 2008 http://www.peh-med.com/content/4/1/1 [possible, economics/access/AIDS]
VV Principlism, medical individualism, and health promotion in resource-poor countries: can autonomy-based bioethics promote social justice and population health? Jacquineau Azétsop1* and Stuart Rennie2,3 http://www.peh-med.com/content/5/1/1
V Living apart together: reflections on bioethics, global inequality and social justice [Congo] Stuart Rennie1* and Bavon Mupenda2 http://www.peh-med.com/content/3/1/25 [2009] [possible; economics/justice dimension]